… of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study …
DF Ionescu, DJ Fu, X Qiu, R Lane, P Lim… - International Journal …, 2021 - academic.oup.com
… a rapid-acting antidepressant in patients with MDD and active … , change in CGI-SS-r from
baseline to 24 hours after the first … 90, indicating the patient was normal/questionably suicidal. …
baseline to 24 hours after the first … 90, indicating the patient was normal/questionably suicidal. …
… esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study
V Popova, EJ Daly, M Trivedi… - American Journal of …, 2019 - Am Psychiatric Assoc
… This study compared the efficacy and safety of switching patients with treatment-resistant …
randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. …
randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. …
[HTML][HTML] Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder
… patients with MDD unresponsive to standard antidepressants… the first antidepressant treatment.
Moreover, the response to … change from baseline were observed on day 14 for patients in …
Moreover, the response to … change from baseline were observed on day 14 for patients in …
[HTML][HTML] … (SAMe) and Lactobacillus plantarum HEAL9 improves the mild-to-moderate symptoms of depression: a randomized, double-blind, placebo-controlled study
A Saccarello, P Montarsolo, I Massardo… - The primary care …, 2020 - psychiatrist.com
… severity of the symptoms unlike traditional antidepressants … In a double-blind randomized
trial,27 the addition of SAMe to … patients with major depressive disorder. In a small, open-label, …
trial,27 the addition of SAMe to … patients with major depressive disorder. In a small, open-label, …
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control
F Yousefzadeh, E Sahebolzamani, A Sadri… - International Clinical …, 2020 - journals.lww.com
… (SSRIs) are more effective in patients with resistant OCD than severe major depressive
disorder… Y-BOCS total score change from baseline to the end of the trial between the two groups. …
disorder… Y-BOCS total score change from baseline to the end of the trial between the two groups. …
[HTML][HTML] … , placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder
MS Abdallah, AN Ramadan… - CNS neuroscience & …, 2021 - ncbi.nlm.nih.gov
… , this study is the first double‐blind, randomized, and placebo‐… restored to the normal levels
by the antidepressant therapy. … a decrease in HDRS after switching from milnacipran to CLS (…
by the antidepressant therapy. … a decrease in HDRS after switching from milnacipran to CLS (…
[HTML][HTML] … , randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder
Q Zhao, B Fu, N Lyu, X Xu, G Huang, Y Tan… - Journal of Affective …, 2023 - Elsevier
… change from baseline in the visual analogue scale for pain (… or caused an inability to perform
normal activities of daily living … antidepressants is 2–4 weeks, which contributes to an early …
normal activities of daily living … antidepressants is 2–4 weeks, which contributes to an early …
[HTML][HTML] … , multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder
W Mi, X Di, Y Wang, H Li, X Xu, L Li, H Wang… - Translational …, 2023 - nature.com
… ) total score change from baseline to the end of the study. Safety … Currently, most approved
antidepressants for MDD primarily … as first-line treatment for most patients with MDD. The …
antidepressants for MDD primarily … as first-line treatment for most patients with MDD. The …
Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial
TS Firoozeei, M Barekatain, M Karimi… - Journal of Integrative …, 2020 - Elsevier
… improved after shifting the time of taking the medicine to the early evening … antidepressant
effects in conjunction with conventional antidepressant drugs in patients with major depression…
effects in conjunction with conventional antidepressant drugs in patients with major depression…
[HTML][HTML] A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment …
… , met criteria for major depressive disorder (MDD) by the … to at least two adequate
antidepressant trials of different … in this study, this is the largest randomized study that compare …
antidepressant trials of different … in this study, this is the largest randomized study that compare …